279 related articles for article (PubMed ID: 25987700)
1. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
[TBL] [Abstract][Full Text] [Related]
3. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
[TBL] [Abstract][Full Text] [Related]
4. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
6. Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.
Tai CH; Wu CC; Hwang ME; Saraf A; Grubb C; Jani A; Lapa ME; Andrews JIS; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJ
CNS Oncol; 2018 Jan; 7(1):25-34. PubMed ID: 29392968
[TBL] [Abstract][Full Text] [Related]
7. Validity of three recently proposed prognostic grading indexes for breast cancer patients with radiosurgically treated brain metastases.
Yamamoto M; Kawabe T; Higuchi Y; Sato Y; Barfod BE; Kasuya H; Urakawa Y
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1110-5. PubMed ID: 22516807
[TBL] [Abstract][Full Text] [Related]
8. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
J Clin Oncol; 2012 Feb; 30(4):419-25. PubMed ID: 22203767
[TBL] [Abstract][Full Text] [Related]
9. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):334-343. PubMed ID: 32084525
[TBL] [Abstract][Full Text] [Related]
10. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
Chiou SM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1156-62. PubMed ID: 20970031
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
[TBL] [Abstract][Full Text] [Related]
12. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto WA; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; An Y; Chiang V; Nakano T; Aoyama H; Mehta MP
J Clin Oncol; 2020 Nov; 38(32):3773-3784. PubMed ID: 32931399
[TBL] [Abstract][Full Text] [Related]
13. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
[TBL] [Abstract][Full Text] [Related]
14. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
[TBL] [Abstract][Full Text] [Related]
15. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases.
Fabregat-Franco C; Stradella A; Navarro V; Linares J; Galdeano M; Recalde S; Velasco R; Simo M; Fernadez A; Venthecourt AC; Falo C; Vazquez S; Bergamino M; Villanueva R; Pernas S; Gil-Gil MJ
Clin Transl Oncol; 2021 Sep; 23(9):1761-1768. PubMed ID: 33704689
[TBL] [Abstract][Full Text] [Related]
16. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
Sperduto CM; Watanabe Y; Mullan J; Hood T; Dyste G; Watts C; Bender GP; Sperduto P
J Neurosurg; 2008 Dec; 109 Suppl():87-9. PubMed ID: 19123893
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
18. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
[TBL] [Abstract][Full Text] [Related]
19. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
20. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC
Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]